-
Mashup Score: 0
Pembrolizumab plus chemotherapy did not improve disease-free survival in patients with newly diagnosed, high-risk endometrial cancer, missing the primary end point of the phase 3 KEYNOTE-B21 study.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Patients with Bacillus Calmette–Guérin-unresponsive high-risk non–muscle-invasive bladder cancer treated with TAR-200 exhibited a high complete response rate to the treatment.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
An expert discussed a screening tool that she and her colleagues used to connect patients with cancer to palliative care services in a more effective way.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Patients with newly diagnosed and recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer treated with UGN-102 displayed meaningful and similar responses and disease-free survival regardless of whether they underwent surgery.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
A nurse-driven, verbal workflow to place tocilizumab orders contributed to safer and more effective delivery of tocilizumab for cytokine release syndrome.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
A screening test has been approved by the FDA for adults 45 years of age or older with an average risk for developing colorectal cancer.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Patients with untreated mantle cell lymphoma treated with acalabrutinib plus bendamustine and rituximab had significant improvements in progression-free survival compared with bendamustine and rituximab alone.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
After reviewing the evidence, nurses switched from heparin-based flushes to all saline flushes for patients disconnecting chemotherapy at home.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
The journey toward vicarious resilience is not only possible but essential—for ourselves, our patients, and it is the very essence of health care.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer treated with nadofaragene firadenovec experienced lasting responses to the therapy for up to 3 years.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
Pembrolizumab plus chemotherapy did not improve disease-free survival in patients with newly diagnosed, high-risk endometrial cancer, missing the primary end point of the phase 3 KEYNOTE-B21 study. https://t.co/apn38QHluu